Poland· PL-100440115
Enerzair Breezhaler
A indacaterol, glycopyrronium bromid und mometason product containing indacaterolum + glycopyrronii bromidum + mometasoni furoas, registered in Poland by Novartis Europharm Limited. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Indacaterol, glycopyrronium bromid und mometason is registered in 11 of 19 countries.
Countries holding a registration under ATC R03AL12 (indacaterol, glycopyrronium bromid und mometason), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Indacaterol, glycopyrronium bromid und mometason · ATC R03AL12
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Indacaterolum + Glycopyrronii bromidum + Mometasoni furoas
- Manufacturer
- Novartis Europharm Limited
- Country
- Poland (PL)
- ATC code
- R03AL12
- ATC class
- Indacaterol, Glycopyrronium bromid und Mometason
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
1 priced- gtin0761342104459630 szt.PLN 196.09
- gtin07613421044619
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Indacaterol, glycopyrronium bromid und mometason in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandEnerzair Breezhaler Inha
- SpainENERZAIR BREEZHALER 114 MICROGRAMOS/46 MICROGRAMOS/136 MICROGRAMOS POLVO PARA INHALACION (CAPSULA DURA)Novartis Europharm Limited
- IcelandEnerzair BreezhalerNovartis Europharm Limited*
- NetherlandsEnerzair Breezhaler 114 micrograms/46 micrograms/136 micrograms, inhalatiepoeder in harde capsuleNovartis Europharm Limited
- CanadaENERZAIR BREEZHALERNOVARTIS PHARMACEUTICALS CANADA INC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3e0d73a4-129d-422a-83fd-f47f0c5d2887 GET /v1/drugs/3e0d73a4-129d-422a-83fd-f47f0c5d2887?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek do inhalacji w kapsułkach twardych",
"source": "urpl",
"strength": "(114 mcg + 46 mcg + 136 mcg)/dawkę",
"packaging": "07613421044619 ¦ Rp ¦ Skasowane ¦ EU/1/20/1438/001 ¦ 137345\n10 kaps. (10 x 1)\nRp ¦ EU/1/20/1438/003 ¦ 137346\n30 kaps. ¦ 1 inhalator + 1 czujnik\n07613421044596 ¦ Rp ¦ EU/1/20/1438/002 ¦ 137347\n30 kaps. ¦ 1 inhalator \nRp ¦ EU/1/20/1438/004 ¦ 137348\n90 kaps. ¦ 1 inhalator \nRp ¦ EU/1/20/1438/005 ¦ 137349\n150 kaps. ¦ 15 inhalatorów",
"substance": "Indacaterolum 114 mcg/dawkę + Glycopyrronii bromidum 58 mcg/dawkę + Mometasoni furoas 136 mcg",
"common_name": "Indacaterolum + Glycopyrronii bromidum + Mometasoni furoas",
"pl_product_id": "100440115",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about indacaterol, glycopyrronium bromid und mometason.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.